Search the Newsreel

Assured Guaranty (AGO) Stock Looks Below Fair Value With Strong Returns But Weak Near Term Price Action

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Assured Guaranty stock has pulled back in the short term, yet over five years …

PROTAGONIST THERAPEUTICS, INC. : WEDBUSH RAISES TARGET PRICE TO $173 FROM $118

Wedbush has increased its target price for Protagonist Therapeutics, Inc. to $173, up from the previous $118. The information is provided by Reuters and indicates a significant positive revision in the analyst's outlook for the company's stock.

Truist Adjusts Price Target on Protagonist Therapeutics to $170 From $145, Maintains Buy Rating

Truist has raised its price target for Protagonist Therapeutics (NASDAQ: PTGX) from $145 to $170, while maintaining a "Buy" rating on the stock. This adjustment reflects a continued positive outlook from the firm on the biopharmaceutical company. Other analysts, including Goldman Sachs and Wedbush, …

Assured Guaranty (AGO) Could Be 18% Undervalued After Second Quarter Earnings

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Second quarter earnings set the tone for Assured Guaranty Assured Guaranty (AGO) drew fresh …

Goldman Sachs upgrades Protagonist Therapeutics stock rating on drug potential

Goldman Sachs upgraded Protagonist Therapeutics (NASDAQ:PTGX) to Buy from Neutral, raising its price target to $186 from $110, citing the potential of its oral IL-17 drug, PN-881. The company recently reported strong Q2 2026 financial results, including significant license and collaboration revenue and a …

S.A.S. Dragon Sets Board Meeting to Approve 2026 Interim Results and Consider Dividend

Mazagon Dock Shipbuilders shares gain 2.15% to Rs 2,569.00

NovaGold Resources Inc (NG) Earnings Forecast: Future EPS & Revenue Growth Estimates

OceanaGold Corporation Ord Shs (OGC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors

Agomab Therapeutics NV announced the proposed appointments of Marino Garcia and Dr. Naimish Patel to its Board of Directors, pending shareholder approval at a Special General Meeting on September 11, 2026. Marino Garcia brings extensive experience in biotechnology leadership and financing, currently serving as …

Protagonist Therapeutics (PTGX) Swings To Net Income, Is The Valuation Too Expensive?

Protagonist Therapeutics (PTGX) recently reported a swing to net income of US$162.85 million in Q2 2026, leading to significant share price momentum. Despite a high Price-to-Earnings ratio of 113.8x compared to industry averages, driven by strong future earnings growth forecasts, the company's Discounted Cash …

Assured Guaranty says annuity business taking off

Assured Guaranty's new Bermudian-based annuity reinsurance platform, Assured Life Re, is developing faster than expected, prompting the company to accelerate bookings and potentially commit more capital. Despite requiring more initial capital, management believes the platform will become self-funding once it scales and plans to …

Assured Guaranty (AGO) Stock Price Sinks As EPS Miss Clouds Core Strength

Assured Guaranty Ltd. (NYSE:AGO) Analysts Just Slashed This Year's Revenue Estimates By 13%

Analysts have significantly revised down their revenue estimates for Assured Guaranty Ltd. (NYSE:AGO) for 2026 by 13%, now forecasting US$767m, a 5.7% decline from the previous year. This downgrade reflects a more pessimistic outlook, with expected annualized revenue decline of 11% by the end …

Quantinno Capital Management LP Boosts Stake in Novagold Resources Inc. $NG

Sei Investments Co. Sells 256,491 Shares of Novagold Resources Inc. $NG

ETFs Investing in S.A.S. Dragon Holdings Limited Stocks

Redemptions cut Rising Dragon (NASDAQ: RDAC) trust assets to $18.37M

Rising Dragon Acquisition Corp. (NASDAQ: RDAC) reported that its trust assets have been significantly reduced to $18.37 million following substantial redemptions. The SPAC, which has a merger agreement with HZJL Cayman Limited for $350 million, faces a deadline of August 15, 2026, to complete …

Agora Inc (API) Stock News Today

This article provides a brief update on Agora Inc (API) stock, noting its current market price, daily change, market cap, and P/E ratio. It states that more news on Agora Inc is expected soon, encouraging readers to stay tuned for further developments.

AgomAb Therapeutics NV Stock 12‑Month Price Target Cut to $33.16, Implies 146% Upside

AgomAb Therapeutics NV's average 12-month price target has been lowered slightly from $34.2 to $33.16 by six analysts, with forecasts ranging from $27.96 to $36.27 per share. Despite the cut, this updated target still suggests a significant upside of approximately 146% from its recent …

Why Protagonist Therapeutics (PTGX) Is Up 6.8% After Swinging to Q2 Profitability and Expanding ESOP

Reinhart Partners LLC. Sells 40,992 Shares of Assured Guaranty Ltd. $AGO

Reinhart Partners LLC significantly reduced its stake in Assured Guaranty Ltd. by selling 40,992 shares in the second quarter, although it still holds 1.25 million shares worth nearly $100 million. This comes as Assured Guaranty reported disappointing second-quarter earnings, missing EPS and revenue estimates, …

Protagonist Therapeutics (NASDAQ:PTGX) Rating Lowered to Buy at Wall Street Zen

Wall Street Zen has downgraded Protagonist Therapeutics (NASDAQ:PTGX) from a "strong buy" to a "buy" rating. Despite this, the broader analyst consensus remains a "Moderate Buy" with an average price target of $126.71. The company recently reported strong quarterly earnings, beating estimates with $2.29 …

Agora (NASDAQ:API) Upgraded at Wall Street Zen

Wall Street Zen upgraded Agora (NASDAQ:API) from "hold" to "buy," while Bank of America reiterated its "buy" rating, though the broader analyst consensus remains "Hold." The company's shares were up 7.5% at $4.46 following a recent earnings report where it beat EPS expectations by …

Winnebago Industries Inc (WGO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Dragon Mining Sets August Board Meeting to Approve Interim Results and Consider Dividend

Success Dragon International Holdings' (HKG:1182) Earnings Are Of Questionable Quality

Winnebago Industries, Inc. (WGO) Stock Forecasts

Argus provided an investment report on Winnebago Industries (WGO), a manufacturer of motor homes, towables, and other specialty vehicles. The report indicates WGO's current price is $32.16 and suggests upgrading to access the full research and additional trade insights. The report was published on …

Rising Dragon Acquisition Corp. Q2 2026: Net income $84.66K, EPS $0.04— 10-Q Summary

Rising Dragon Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Protagonist Therapeutics (PTGX): State Street discloses 5.2% beneficial ownership stake

State Street Corporation has reported a 5.2% passive beneficial ownership stake in Protagonist Therapeutics, Inc., holding 3,321,554 common shares. The filing indicates that State Street exercises shared voting power over 3,157,671 shares and shared dispositive power over all 3,321,554 shares through various investment management …

Assured Guaranty Releases Q2 2026 Financial Results

Assured Guaranty Ltd. (AGO) reported its Q2 2026 financial results, with adjusted operating income of $1.23 per share, missing the Wall Street consensus. The company generated $195.0 million in revenue, a 30.6% decline year-over-year, and net income of $55.0 million. Despite the revenue contraction, …

Assured Guaranty Ltd (AGO) (Q2 2026) Earnings Call Highlights: Record Book Value and 48% Surge ...

This article first appeared on GuruFocus. Adjusted Operating Income: $55 million, or $1.23 per share, in Q2 2026, a 22% increase year-over-year. Net Earned Premiums: Increased due to higher refundings and scheduled net earned premiums, driven by growth in shorter-duration strategies like fund finance. …

OceanaGold (TSX:OGC) Q2 Results Put Its Undervalued Narrative Back In Focus

Friday's ETF Movers: SGDM, IAK

In trading on Friday, the Sprott Gold Miners ETF is outperforming other ETFs, up about 7.4% on the day. Components of that ETF showing particular strength include shares of Aura Minerals, up about 12.5% and shares of Anglogold Ashanti, up about 10.8% on the …

Assured Guaranty's three per-share metrics hit record highs in Q2

Assured Guaranty Ltd. (NYSE: AGO) announced record-high per-share valuation metrics for Q2 2026, with shareholders’ equity at $126.18, adjusted operating shareholders’ equity at $129.94, and adjusted book value at $189.72. The company reported solid new business production in the first half of 2026, with …